SYDNEY, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Building a beautiful, functional outdoor space can add value to any home and provide an elevated living and entertaining experience for homeowners. However, family-owned South Australian company and #" decking decking
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26